Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception
- PMID: 22209059
- DOI: 10.1016/j.jvoice.2011.08.016
Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception
Abstract
Objectives: Perceptual judgments and patients' perception of voice and speech after concurrent chemoradiotherapy (CCRT) for advanced head and neck cancer.
Study design: Prospective clinical trial.
Methods: A standard Dutch text and a diadochokinetic task were recorded. Expert listeners rated voice and speech quality (based on Grade, Roughness, Breathiness, Asthenia, and Strain), articulation (overall, [p], [t], [k]), and comparative mean opinion scores of voice and speech at three assessment points calculated. A structured study-specific questionnaire evaluated patients' perception pretreatment (N=55), at 10-week (N=49) and 1-year posttreatment (N=37).
Results: At 10 weeks, perceptual voice quality is significantly affected. The parameters overall voice quality (mean, -0.24; P=0.008), strain (mean, -0.12; P=0.012), nasality (mean, -0.08; P=0.009), roughness (mean, -0.22; P=0.001), and pitch (mean, -0.03; P=0.041) improved over time but not beyond baseline levels, except for asthenia at 1-year posttreatment (voice is less asthenic than at baseline; mean, +0.20; P=0.03). Perceptual analyses of articulation showed no significant differences. Patients judge their voice quality as good (score, 18/20) at all assessment points, but at 1-year posttreatment, most of them (70%) judge their "voice not as it used to be." In the 1-year versus 10-week posttreatment comparison, the larynx-hypopharynx tumor group was more strained, whereas nonlarynx tumor voices were judged less strained (mean, -0.33 and +0.07, respectively; P=0.031). Patients' perceived changes in voice and speech quality at 10-week post- versus pretreatment correlate weakly with expert judgments.
Conclusion: Overall, perceptual CCRT effects on voice and speech seem to peak at 10-week posttreatment but level off at 1-year posttreatment. However, at that assessment point, most patients still perceive their voice as different from baseline.
Copyright © 2012 The Voice Foundation. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy.Oral Oncol. 2016 Apr;55:24-30. doi: 10.1016/j.oraloncology.2016.02.001. Epub 2016 Feb 10. Oral Oncol. 2016. PMID: 26874554
-
Voice outcomes after concurrent chemoradiotherapy for advanced nonlaryngeal head and neck cancer: a prospective study.Head Neck. 2012 Dec;34(12):1747-52. doi: 10.1002/hed.22003. Epub 2012 Feb 9. Head Neck. 2012. PMID: 22319013
-
Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1395-9. doi: 10.1016/j.ijrobp.2005.05.004. Epub 2005 Aug 8. Int J Radiat Oncol Biol Phys. 2005. PMID: 16087298 Clinical Trial.
-
Effects of chemoradiotherapy on voice and swallowing.Curr Opin Otolaryngol Head Neck Surg. 2009 Jun;17(3):172-8. doi: 10.1097/MOO.0b013e32832af12f. Curr Opin Otolaryngol Head Neck Surg. 2009. PMID: 19337126 Free PMC article. Review.
-
Perceptual evaluation of voice quality: review, tutorial, and a framework for future research.J Speech Hear Res. 1993 Feb;36(1):21-40. doi: 10.1044/jshr.3601.21. J Speech Hear Res. 1993. PMID: 8450660 Review.
Cited by
-
Binary Logistic Regression Modeling of Voice Impairment and Voice Assessment in Iranian Patients with Nonlaryngeal Head-and-Neck Cancers after Chemoradiation Therapy: Objective and Subjective Voice Evaluation.J Med Signals Sens. 2023 Mar 27;13(1):40-48. doi: 10.4103/jmss.jmss_143_21. eCollection 2023 Jan-Mar. J Med Signals Sens. 2023. PMID: 37292443 Free PMC article.
-
Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature.Biomed Res Int. 2016;2016:6086894. doi: 10.1155/2016/6086894. Epub 2016 Sep 19. Biomed Res Int. 2016. PMID: 27722170 Free PMC article.
-
Cancer Prehabilitation for Patients Starting from Active Treatment to Surveillance.Asia Pac J Oncol Nurs. 2016 Jan-Mar;3(1):37-40. doi: 10.4103/2347-5625.178169. Asia Pac J Oncol Nurs. 2016. PMID: 27981135 Free PMC article. Review.
-
Prediction of Speech Impairment in Patients Treated for Oral or Oropharyngeal Cancer Using Automatic Speech Analysis.Int J Lang Commun Disord. 2025 Sep-Oct;60(5):e70103. doi: 10.1111/1460-6984.70103. Int J Lang Commun Disord. 2025. PMID: 40755165 Free PMC article.
-
Radiation-induced neuropathies in head and neck cancer: prevention and treatment modalities.Ecancermedicalscience. 2020 Nov 3;14:1133. doi: 10.3332/ecancer.2020.1133. eCollection 2020. Ecancermedicalscience. 2020. PMID: 33281925 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical